Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vyanka Redenbaugh

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Pediatrics|August 23, 2021
Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta SyndromesVyanka Redenbaugh, Tanya Coulter
The Lancet Regional Health. Western Pacific|February 3, 2022
Understanding the etiology and epidemiology of meningitis and encephalitis: now and into the futureVyanka Redenbaugh, Eoin P Flanagan
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 10, 2022
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGADVyanka Redenbaugh, Eoin P Flanagan
Frontiers in Allergy|April 7, 2022
Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous UrticariaKatie Ridge, Vyanka Redenbaugh, Niall Conlon
Irish Journal of Medical Science|January 21, 2019
Food-dependent exercise-induced reactions: lessons from a 15-year retrospective studyAisling Farrell, Ciaran Judge, Vyanka Redenbaugh, et al.
Journal of Clinical Immunology|December 23, 2022
XLA and Recurrent Conjunctivitis: a Unique Association?Vyanka Redenbaugh, Anne Sloan, Jacklyn Sui, et al.
Irish Journal of Medical Science|January 14, 2022
The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosisAudrey Reynolds, Maria Gaughan, Dean Holden, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2023
Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosisNicholas H Chia, Vyanka Redenbaugh, John J Chen, et al.
Journal of the Neurological Sciences|May 18, 2023
Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MSLauren M Webb, Laura Cacciaguerra, Karl N Krecke, et al.
Annals of Clinical and Translational Neurology|January 18, 2024
Peripheral nervous system manifestations of MOG antibody associated diseasePranjal Gupta, Pritikanta Paul, Vyanka Redenbaugh, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Pediatrics|August 23, 2021
Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta SyndromesVyanka Redenbaugh, Tanya Coulter
The Lancet Regional Health. Western Pacific|February 3, 2022
Understanding the etiology and epidemiology of meningitis and encephalitis: now and into the futureVyanka Redenbaugh, Eoin P Flanagan
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 10, 2022
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGADVyanka Redenbaugh, Eoin P Flanagan
Frontiers in Allergy|April 7, 2022
Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous UrticariaKatie Ridge, Vyanka Redenbaugh, Niall Conlon
Irish Journal of Medical Science|January 21, 2019
Food-dependent exercise-induced reactions: lessons from a 15-year retrospective studyAisling Farrell, Ciaran Judge, Vyanka Redenbaugh, et al.
Journal of Clinical Immunology|December 23, 2022
XLA and Recurrent Conjunctivitis: a Unique Association?Vyanka Redenbaugh, Anne Sloan, Jacklyn Sui, et al.
Irish Journal of Medical Science|January 14, 2022
The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosisAudrey Reynolds, Maria Gaughan, Dean Holden, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2023
Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosisNicholas H Chia, Vyanka Redenbaugh, John J Chen, et al.
Journal of the Neurological Sciences|May 18, 2023
Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MSLauren M Webb, Laura Cacciaguerra, Karl N Krecke, et al.
Annals of Clinical and Translational Neurology|January 18, 2024
Peripheral nervous system manifestations of MOG antibody associated diseasePranjal Gupta, Pritikanta Paul, Vyanka Redenbaugh, et al.
Pageof 4